-
HIV/AIDS providers from across the United States felt some of the repercussions of Hurricane Katrina's devastation of New Orleans three years ago.
-
Biomedical research has become so sophisticated in the 21st century that future principal investigators (PIs) might need to have in-depth knowledge about more than one discipline in order to stay competitive.
-
Before Emory University in Atlanta completely revamped its clinical trials billing process, most of the CT budgeting and analyses were done by individual departments.
-
One of the key strategies to retaining clinical trial enrollment, particularly when the participants are from vulnerable populations, is exhibiting respect and a nonjudgmental attitude during all encounters, an expert says.
-
A recent judge's ruling has shaken up the clinical research industry as experts try to determine how the court's interference in an investigational drug study might impact future CT recruitment.
-
-
It's one thing to sense that IRBs are demanding more and are becoming more cautious during protocol reviews. But it's the rare principal investigator who has a long, multi-site study in which it's readily apparent that the IRB reviews have become more rigorous.
-
Methamphetamine ("meth") addicts are one of the more difficult research populations to recruit both for the erratic lifestyles many have and the illicit drug's tendency to make people paranoid.
-
One of the biggest challenges facing case managers today is educating the consumer and other health care providers about what case managers do and the value they bring to the table, says Jeff Frater, RN, BSN, CCM, new president for the Case Management Society of America (CMSA).
-
The goal of Health Net's Special Needs Plan for seniors with elevated cholesterol is to empower the members to become more informed and responsible for their own medical care in cooperation and collaboration with their physicians, says Richard Jacobs, MD, MBA, chief medical officer for Health Net of Arizona Inc.